Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

Tumour Tissue ◽

Isolated Limb Perfusion ◽

Necrosis Factor Alpha ◽

Limb Perfusion ◽

Factor Alpha ◽

Effects of isolated limb perfusion with tumour necrosis factor-alpha on the function of monocytes and T lymphocytes in patients with cancer

European Journal of Clinical Investigation ◽

10.1046/j.1365-2362.1996.480599.x ◽

1996 ◽

Vol 26 (12) ◽

pp. 1085-1091 ◽

Cited By ~ 9

Author(s):

T. C. STAM ◽

M. JONGEN-LAVRENCIC ◽

A. M. M. EGGERMONT ◽

A. J. G. SWAAK

Keyword(s):

T Lymphocytes ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Isolated Limb Perfusion ◽

Necrosis Factor Alpha ◽

Patients With Cancer ◽

Limb Perfusion ◽

Factor Alpha ◽

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats

British Journal of Cancer ◽

10.1038/sj.bjc.6690335 ◽

1999 ◽

Vol 80 (1-2) ◽

pp. 161-166 ◽

Cited By ~ 92

Author(s):

J H W de Wilt ◽

E R Manusama ◽

S T van Tiel ◽

M G A van Ijken ◽

T L M ten Hagen ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Isolated Limb Perfusion ◽

Necrosis Factor Alpha ◽

Limb Perfusion ◽

Factor Alpha ◽

Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-alpha and melphalan

British Journal of Dermatology ◽

10.1046/j.1365-2133.1999.03179.x ◽

1999 ◽

Vol 141 (5) ◽

pp. 935-936 ◽

Cited By ~ 4

Author(s):

A.C. Haffner ◽

K. Zepter ◽

T. Fritz ◽

R. Dummer ◽

F.J. Lejeune ◽

...

Keyword(s):

Complete Remission ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Isolated Limb Perfusion ◽

High Dose ◽

Necrosis Factor Alpha ◽

Limb Perfusion ◽

Factor Alpha ◽

Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma

International Journal of Cancer ◽

10.1002/ijc.29059 ◽

2014 ◽

Vol 136 (4) ◽

pp. 965-976 ◽

Cited By ~ 14

Author(s):

Tim D. Pencavel ◽

Michelle J. Wilkinson ◽

David C. Mansfield ◽

Aadil A. Khan ◽

Rohit Seth ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Rat Model ◽

Tumour Necrosis ◽

Tumour Targeting ◽

Necrosis Factor Alpha ◽

Extremity Sarcoma ◽

Limb Perfusion ◽

Factor Alpha ◽

Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway

Journal of Controlled Release ◽

10.1016/j.jconrel.2011.08.022 ◽

2011 ◽

Vol 156 (3) ◽

pp. 381-389 ◽

Cited By ~ 32

Author(s):

Takahiro Seki ◽

Fionnadh Carroll ◽

Sam Illingworth ◽

Nicky Green ◽

Ryan Cawood ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Rho Kinase ◽

Tumour Tissue ◽

Necrosis Factor Alpha ◽

Virus Particles ◽

Factor Alpha ◽

Kinase Pathway ◽

Short-term histopathological response to anti-tumour necrosis factor alpha therapy in patients with ulcerative colitis

10.26226/morressier.596dfd59d462b80292387586 ◽

2017 ◽

Author(s):

Diana-Alexandra Costache

Keyword(s):

Ulcerative Colitis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Short Term ◽

Histopathological Response ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Therapy ◽

Faculty Opinions recommendation of A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120210.576363 ◽

2008 ◽

Author(s):

John Atkinson

Keyword(s):

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Cord Factor ◽

Factor Alpha ◽

Necrosis Factor ◽

Granulomatous Response

Faculty Opinions recommendation of Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1162910.623534 ◽

2009 ◽

Author(s):

Ulf Müller-Ladner

Keyword(s):

Tumour Necrosis Factor ◽

Dose Escalation ◽

Inflammatory Arthritis ◽

Tumour Necrosis ◽

Phase 1 ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Antagonist ◽

Faculty Opinions recommendation of Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2695956.2359056 ◽

2010 ◽

Author(s):

Scott Davies

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Fungal Infections ◽

Inhibitor Therapy ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Tumour necrosis factor-alpha polymorphism -308 G/a and its protein in subjects with gingivitis

Acta Odontologica Scandinavica ◽

10.1080/00016357.2021.1928280 ◽

2021 ◽

pp. 1-6

Author(s):

Julieta Sarai Becerra-Ruiz ◽

Saúl Ramírez-De los Santos ◽

Carmen Celina Alonso-Sánchez ◽

Fernando Martínez-Esquivias ◽

Luz Andrea Martínez-Pérez ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽